SCHEMBL10692939

SCHEMBL10692939

CC(C(=O)N(O)CCc1ccccc1)c1cccc(OCc2ccccc2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 5/20 1.00
LTB4R Q15722 1/20 0.55
LTB4R2 Q9NPC1 1/20 0.55
KMT2A Q03164 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
BCHE P06276 4/20 0.49
GLI1 P08151 1/20 0.48
GLI2 P10070 1/20 0.48
MAOB P27338 1/20 0.48
PTGES O14684 1/20 0.47
FFAR1 O14842 1/20 0.47
NR4A2 P43354 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2986567 0.81 ALOX5 (0.67) ALOX5KMT2ASMN1; SMN2BCHEMAOB
SCHEMBL27833465 0.81 ALOX5 (0.67) ALOX5KMT2ASMN1; SMN2BCHEMAOB
SCHEMBL10691751 0.80 GLI1 (0.69) ALOX5KMT2ASMN1; SMN2GLI1GLI2
SCHEMBL2853880 0.78 ALOX5 (0.63) ALOX5KMT2ASMN1; SMN2BCHEMAOB
SCHEMBL23923495 0.74 KMT2A (0.61) ALOX5KMT2ASMN1; SMN2BCHEMAOB
SCHEMBL31748975 0.74 KMT2A (0.61) ALOX5KMT2ASMN1; SMN2BCHEMAOB
SCHEMBL12221485 0.74 KMT2A (0.61) ALOX5KMT2ASMN1; SMN2BCHEMAOB
SCHEMBL684282 0.74 MAOB (0.62) ALOX5KMT2ASMN1; SMN2BCHEMAOB
SCHEMBL29216490 0.74 KMT2A (0.58) ALOX5KMT2ASMN1; SMN2BCHEMAOB
SCHEMBL11922929 0.73 BCHE (0.60) ALOX5KMT2ASMN1; SMN2BCHEMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0196674-A2 Hydroxamates as modulators of arachidonic acid metabolic pathways USV PHARMACEUTICAL CORPORATION (US) 1986-10-08 EP claimed
US-4792560-A ANTIALLERGENS; ANTIINFLAMMATORY AGENTS RORER PHARMACEUTICAL CORPORATION (US) 1988-12-20 US disclosed
EP-0196674-A2 Hydroxamates as modulators of arachidonic acid metabolic pathways USV PHARMACEUTICAL CORPORATION (US) 1986-10-08 EP disclosed